Market Research Report

A quick peek into the report

NGS Oncology Market - A Global and Regional Analysis

Focus on Offering, Sequencing Technology, Workflow, Application, End User, and Region - Analysis and Forecast, 2022-2032

 
Some Faq's

Frequently Asked Questions

NGS oncology is the application of next-generation sequencing technology for cancer. The technology is a valuable method for obtaining deeper and more accurate insights into the molecular underpinnings of a patient's tumor.

The key trends in the global NGS oncology market include NGS-based oncology products and services that have witnessed significant growth due to several approvals. For instance, in August 2021, Pillar Biosciences' oncoReveal Dx Lung & Colon Cancer Assay was approved by the Food and Drug Administration (FDA) for somatic mutation detection and research usage to the market growth. This momentous trend is expected to continue as the major players in the global NGS oncology market have a significant number of products in the pipeline.

The global NGS oncology market has seen significant development by key players operating in the market, such as business expansion, partnership, collaboration, and joint venture. According to BIS Research analysis, most companies preferred partnerships, collaborations, and joint ventures as a strategy to further boost their growth in the global NGS oncology market. Companies such as Illumina, Inc., Thermo Fisher Scientific Inc., F-Hoffmann-La Roche Ltd., QIAGEN N.V, and Agilent Technologies, Inc. have majorly adopted partnerships, collaborations, and joint venture strategies.

A new entrant can focus on various new technologies being used for diagnosis and services offered by the established market players of NGS oncology.

•    Extensive competitive benchmarking of the top 18 players has been done to offer a holistic view of the global NGS Oncology market landscape.
•    Market ranking analysis based on product portfolio, recent development activities, and regional spread.
•    Investment landscape including product adoption scenario, funding, and patent analysis.

The NGS oncology kit service providers, technology providers, pharmaceutical companies, and research institutions should buy this report.

Similar Product

You may also like

Oncology Precision Medicine Market - A Global and Regional Analysis
Published Year: 2022

Oncology Precision Medicine Market - A Global and Regional Analysis: Focus on Ecosystem and Applicat

The global oncology precision medicine market was valued at $45,174.2 million in 2020 and is...

NGS Sample Preparation Market - A Global and Regional Analysis
Published Year: 2022

NGS Sample Preparation Market - A Global and Regional Analysis: Focus on Product, Workflow, Therapeu

The global NGS sample preparation market is projected to reach $3,279.3 million by 2026,...